Table 2.
Predictors in model | Odds ratio | 95% CI | p value | |
---|---|---|---|---|
Lower | Upper | |||
Gender | 1.09 | 0.82 | 1.37 | 0.57 |
Age | 1.01 | 1.00 | 1.03 | 0.15 |
Comorbidity | ||||
Heart disease | 0.76 | 0.53 | 1.12 | 0.14 |
Hypertension | 0.86 | 0.65 | 1.14 | 0.30 |
Lung disease | 0.89 | 0.57 | 1.33 | 0.60 |
Vascular disease | 0.71 | 0.38 | 1.33 | 0.28 |
Neurological disease | 1.19 | 0.58 | 1.90 | 0.64 |
Diabetes mellitus | 0.85 | 0.56 | 1.25 | 0.42 |
Gastric ulceration | 1.40 | 0.66 | 2.16 | 0.38 |
Kidney disease | 0.38 | 0.16 | 1.27 | 0.03 |
Liver disease | 10.47 | 1.13 | 12.70 | 0.05 |
Anaemia | 1.74 | 0.87 | 2.43 | 0.12 |
Back pain | 0.75 | 0.56 | 1.04 | 0.049 |
Depression | 0.80 | 0.53 | 1.21 | 0.28 |
Length of stay | 0.99 | 0.94 | 1.03 | 0.56 |
Prosthesis | ||||
PFC | Reference | |||
Triathlon | 0.91 | 0.69 | 1.22 | 0.53 |
Kinemax | 1.25 | 0.76 | 2.05 | 0.38 |
Functional measures | ||||
OKS | 1.01 | 0.99 | 1.04 | 0.27 |
SF-12 PCS | 1.00 | 0.97 | 1.02 | 0.82 |
SF-12 MCS | 1.03 | 1.02 | 1.04 | <0.001 |
All variables (in Table 1) were all entered into the model using “enter” methodology (Nagelkerke R 2 = 0.06)
Significant values (p < 0.05) have been highlighted in bold